American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$234M |
| 2 |
Unilever
UL
|
+$230M |
| 3 |
Sysco
SYY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$206M |
| 5 |
Sea Limited
SE
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$395M |
| 2 |
Boston Scientific
BSX
|
+$331M |
| 3 |
Illumina
ILMN
|
+$318M |
| 4 |
Alibaba
BABA
|
+$296M |
| 5 |
SBA Communications
SBAC
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Financials | 14.89% |
| 3 | Healthcare | 14.13% |
| 4 | Consumer Discretionary | 14.08% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
NOV
NOV
$7.36B
| $7.82M | 0.01% |
569,583
+103,414
| +22% | +$1.17M |
|
802
ArcBest
ARCB
$3.28B
| $7.8M | 0.01% |
182,709
-39,762
| -18% | -$1.51M |
|
803
GCM Grosvenor
GCMG
$2.85B
| $7.76M | 0.01% |
+582,363
| New | +$6.46M |
|
804
Emcor
EME
$36.7B
| $7.74M | 0.01% |
84,584
+79,835
| +1,681% | +$6.41M |
|
805
OrthoPediatrics
KIDS
$653M
| $7.73M | 0.01% |
187,331
+34,810
| +23% | +$1.6M |
|
806
Sanofi
SNY
$105B
| $7.7M | 0.01% |
158,365
+84
| +0.1% | +$4.14K |
|
807
WEC Energy
WEC
$35.9B
| $7.52M | 0.01% |
81,746
+48,380
| +145% | +$4.71M |
|
808
Helen of Troy
HELE
$699M
| $7.51M | 0.01% |
33,792
+3,174
| +10% | +$654K |
|
|
FLXN
809
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $7.5M | 0.01% |
649,708
+53,509
| +9% | +$622K |
|
810
Host Hotels & Resorts
HST
$15.6B
| $7.49M | 0.01% |
+511,742
| New | +$6.62M |
|
811
Fortuna Silver Mines
FSM
$3.1B
| $7.45M | 0.01% |
904,584
+851,473
| +1,603% | +$5.9M |
|
812
Monolithic Power Systems
MPWR
$67B
| $7.42M | 0.01% |
20,255
-18,008
| -47% | -$5.77M |
|
|
TSE
813
DELISTED
Trinseo
TSE
| $7.34M | 0.01% |
143,290
+91,589
| +177% | +$3.49M |
|
814
Evercore
EVR
$12B
| $7.28M | 0.01% |
66,396
+3,615
| +6% | +$322K |
|
|
FBM
815
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $7.22M | 0.01% |
375,994
-1,269,951
| -77% | -$22.4M |
|
|
SP
816
DELISTED
SP Plus Corporation
SP
| $7.18M | 0.01% |
+249,117
| New | +$6.12M |
|
817
West Pharmaceutical
WST
$24.4B
| $7.18M | 0.01% |
25,339
-2,610
| -9% | -$732K |
|
818
SPDR Gold Trust
GLD
$142B
| $7.15M | 0.01% |
40,100
-24,800
| -38% | -$4.37M |
|
819
Lamar Advertising Co
LAMR
$15.8B
| $7.15M | 0.01% |
+85,877
| New | +$6.42M |
|
820
Sprouts Farmers Market
SFM
$7.71B
| $7.14M | 0.01% |
355,456
+25,890
| +8% | +$530K |
|
821
Kohl's
KSS
$2.22B
| $7.1M | 0.01% |
174,405
+78,623
| +82% | +$2.29M |
|
822
NovoCure
NVCR
$2.02B
| $7.07M | 0.01% |
40,875
+24,211
| +145% | +$3.31M |
|
823
Heron Therapeutics
HRTX
$63.5M
| $6.97M | 0.01% |
329,249
-10,136
| -3% | -$176K |
|
|
SGTX
824
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $6.94M | 0.01% |
+11,121
| New | +$5.05M |
|
825
Enphase Energy
ENPH
$5.39B
| $6.9M | 0.01% |
39,334
+10,539
| +37% | +$1.34M |
|
Similar funds
American Century Companies's Q4 2020 Portfolio in Review
As of Q4 2020, American Century Companies held 2,076 positions worth $128B, up 14% from $113B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
American Century Companies's Q4 2020 filing shows 276 new, 1,105 increased, 539 reduced and 122 closed positions. Its largest new stake was Crane NXT: 2,746,264 shares worth $74.1M. The largest sale was iShares Russell 1000 Value ETF, an estimated $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2020 buy was Crane NXT: 2,746,264 shares worth $74.1M.
- American Century Companies added most to Colgate-Palmolive in Q4 2020, an estimated $234M increase.
- American Century Companies's biggest Q4 2020 reduction was iShares Russell 1000 Value ETF, cutting an estimated $395M.
- American Century Companies fully exited Wells Fargo 7.5% Non Cumv Perp Conv in Q4 2020, selling an estimated $154M.
- American Century Companies's ten largest holdings make up 22% of its $128B portfolio in Q4 2020.
- American Century Companies opened 276 new positions and closed 122 in Q4 2020.
- American Century Companies's portfolio value rose 14% quarter-over-quarter to $128B.
Based on American Century Companies's 13F filing for Q4 2020, filed 12 Feb 2021.